Pubblicazioni scientifiche
Pubblicazioni scientifiche del Registro Tumori Veneto.
Impact of Microscopic Confirmation on Therapeutic Management of Pancreatic Cancer Patients: Lessons from an Italian Regional Tumor Registry
Fantin A, Gruppo M, De Simoni O, Lonardi S, Cristofori C, Morbin T, Peserico G, Grillo S, Masier A, Franco M, Pilati P, Guzzinati S, Zorzi M, Rugge M. Cancers (Basel). 2022 Oct 31;14(21):5372. doi: 10.3390/cancers14215372. Abstract Background: Incidence of pancreatic cancer (PC) is increasing worldwide and is set to become the second leading cause of cancer-related death in 2040 with a poor 5-year overall survival (OS). The aim of this study was to analyze the impact of microscopic diagnosis of PC (MiDPC) on diagnostic−therapeutic management and outcome. Methods: The Veneto region...
Cancer cost profiles: The Epicost estimation approach
Francisci S, Capodaglio G, Gigli A, Mollica C, Guzzinati S. Front Public Health. 2022 Sep 21;10:974505. doi: 10.3389/fpubh.2022.974505. eCollection 2022. Abstract Sustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic burden associated with cancer and identifying effective policies for minimising its impact are important issues for healthcare systems. Scope...
Impact of colorectal cancer screening on incidence, mortality and surgery rates: Evidences from programs based on the fecal immunochemical test in Italy.
Zorzi M, Urso EDL. Dig Liver Dis. 2022 Aug 20:S1590-8658(22)00633-8. doi: 10.1016/j.dld.2022.08.013. Online ahead of print. Abstract Fecal immunochemical tests (FIT) are among the most commonly used tests for colorectal cancer (CRC) screening programs worldwide. However, no randomised controlled trials have been carried out evaluating the impact of FIT-based screening programs (FIT-progr) on CRC incidence and mortality rates. Italian FIT-progr represent one of the most widespread and established experience worldwide. This paper reviews the evidence on the impact of FIT-progr on CRC...
Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective
Buja A, Rugge M, De Luca G, Zorzi M, Cozzolino C, Vecchiato A, Del Fiore P, Tropea S, Bortolami A, Benini P, Rossi CR, Mocellin S. Melanoma Res. 2022 Oct 1;32(5):353-359. doi: 10.1097/CMR.0000000000000841. Epub 2022 Jul 19. Abstract The prognosis of cutaneous malignant melanoma (CMM) is based on disease progression. The highly heterogeneous clinical-pathological characteristics of CMM necessitate standardized diagnostic and therapeutic interventions tailored to cancer's stage. This study utilizes clinical performance indicators to assess the quality of CMM care in Veneto (Northeast Italy)....
Direct Costs of Care for Adults with Soft Tissue Sarcomas: A Population-Based Study
Rugge M, Buja A, Tropea S, Girardi G, Franzese LC, Cozzolino C, Zorzi M, Vecchiato A, Del Fiore P, Brunello A, Brazzale AR, Baldo V, Dei Tos AP, Rossi CR, Mocellin S. Cancers (Basel). 2022 Jun 24;14(13):3109. doi: 10.3390/cancers14133109. Abstract The clinical treatment of soft tissue sarcoma (STS) has evolved substantially over the last decade. This population-based cohort study based on real-world data included all incidental STS recorded by the Veneto Cancer Registry in 2017. Data on hospital admissions, emergency department and outpatient visits, drug prescriptions, and use of medical...
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study
Massari M, Spila Alegiani S, Morciano C, Spuri M, Marchione P, Felicetti P, Belleudi V, Poggi FR, Lazzeretti M, Ercolanoni M, Clagnan E, Bovo E, Trifirò G, Moretti U, Monaco G, Leoni O, Da Cas R, Petronzelli F, Tartaglia L, Mores N, Zanoni G, Rossi P, Samez S, Zappetti C, Marra AR, Menniti Ippolito F; TheShinISS-Vax|COVID Surveillance Group PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul. Abstract Background: Myocarditis and pericarditis following the Coronavirus Disease 2019 (COVID-19) mRNA vaccines administration have been reported, but their...
New childhood cancer survival estimates in Italy
Crocetti E, Ravaioli A, Bucchi L, Guzzinati S, Casella C, Puppo A, Toffolutti F, Zamagni F, Dal Maso L, Italian Cancer Registries WG 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Pamplona, 18-20 may 2022 Abstract Objective. The study of childhood cancer, including survival, has been a commitment of Italian population-based cancer registries since decades, and a couple of reports have been published. The present study updates the last available estimates with more recent data focusing on cancer survival. Methods. Data from...
New childhood cancer survival estimates in Italy
Crocetti E, Ravaioli A, Bucchi L, Guzzinati S, Casella C, Puppo A, Toffolutti F, Zamagni F, Dal Maso L, Italian Cancer Registries WG 46th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). Pamplona, 18-20 may 2022 Abstract Objective. The study of childhood cancer, including survival, has been a commitment of Italian population-based cancer registries since decades, and a couple of reports have been published. The present study updates the last available estimates with more recent data focusing on cancer survival. Methods. Data from...
Argomenti in evidenza
Pubblicazioni scientifiche
Pubblicazioni scientifiche del Registro Tumori Veneto.
Monografie
Report per sede tumorale e monografie.
Congressi e conferenze
Scopri tutte le pubblicazioni orali e i poster.